Natures Sunshine Products Inc
NATRNasdaqCIK 275053HealthcareFiscal year ends Dec 31
Reports and events: 265 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0617:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054468 |
| 2026-08-0616:35 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-054387 |
| 2026-05-1108:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-033161 |
| 2026-05-0717:19 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-032330 |
| 2026-05-0717:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032316 |
| 2026-03-2717:15 ET | DEF 14A | Proxy statementPeriod 2026-03-27 | 0001628280-26-021776 |
| 2026-03-1017:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-016540 |
| 2026-03-1017:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-016535 |
| 2025-11-0617:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000275053-25-000004 |
| 2025-11-0616:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050268 |
| 2025-10-1515:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-045092 |
| 2025-07-3117:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037065 |
| 2025-07-3116:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037004 |
| 2025-07-0716:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-034416 |
| 2025-06-2716:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-023972 |
| 2025-06-2708:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-149772 |
| 2025-06-0916:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-021957 |
| 2025-06-0216:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-028851 |
| 2025-05-0617:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022765 |
| 2025-05-0616:38 ET | 8-K | 9.01 Financial statements and exhibits | 0001628280-25-022734 |
| 2025-03-2010:09 ET | DEF 14A | Proxy statementPeriod 2025-03-20 | 0001628280-25-014027 |
| 2025-03-1218:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-012151 |
| 2025-03-1117:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-012082 |
| 2025-03-1117:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-011764 |
| 2025-02-0516:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-004020 |
| 2024-11-0717:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-046400 |
| 2024-11-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-046299 |
| 2024-08-0913:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036412 |
| 2024-08-0817:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036235 |
| 2024-05-0818:08 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-021241 |
| 2024-05-0717:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021178 |
| 2024-03-1509:14 ET | DEF 14A | Proxy statementPeriod 2024-05-01 | 0001628280-24-011333 |
| 2024-03-1217:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-010625 |
| 2024-03-1216:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-010566 |
| 2024-03-1218:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-010295 |
| 2024-03-0616:04 ET | 8-K/A | 5.07 Shareholder vote results | 0001628280-24-009389 |
| 2023-11-0717:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037449 |
| 2023-11-0717:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037442 |
| 2023-08-1019:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-028711 |
| 2023-08-0917:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-028655 |
| 2023-05-0917:31 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-23-016908 |
| 2023-05-0917:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000275053-23-000007 |
| 2023-03-2410:21 ET | DEF 14A | Proxy statementPeriod 2023-03-24 | 0001628280-23-009101 |
| 2023-03-1613:30 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000275053-23-000005 |
| 2023-03-1617:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-008143 |
| 2023-02-2409:16 ET | 8-K | 8.01 Other events | 0000275053-23-000003 |
| 2023-02-0318:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-002113 |
| 2022-12-2918:59 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-22-032660 |
| 2022-12-0709:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-22-031494 |
| 2022-11-0317:19 ET | 8-K | 9.01 Financial statements and exhibits | 0000275053-22-000024 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.